Key result
Elevated NT-proBNP predicts ~15-fold higher in-hospital mortality in acute infective endocarditis.
Why the study?
Acute infective endocarditis has an often unpredictable outcome due to a lack of reliable prognostic parameters.
Does NT-proBNP level predict in-hospital mortality and 1-year survival in patients with acute infective endocarditis?
Cohort (n=337)
No
Does NT-proBNP level predict in-hospital mortality and 1-year survival in patients with acute infective endocarditis?
Effect estimate: OR 14.9 (95% CI 2.46-90.9)
Absolute Event Rate: 16.7% vs 2.3%
p-value: p=0.003
NT-proBNP is a strong independent predictor of in-hospital mortality and 1-year survival in patients with acute infective endocarditis, supporting its use in risk stratification.
NT-proBNP may aid risk stratification in acute infective endocarditis; leaves open prospective validation before guiding care.
PURPOSE: To explore the prognostic value and the correlates of NT-proBNP in patients with acute infective endocarditis, a life-threatening disease, with an often unpredictable outcome given by the lack of reliable prognostic parameters. METHODS: We retrospectively studied 337 patients admitted to our centre between January 1, 2006 and September 30, 2020 with available NT-proBNP level at admission. Our analyses were performed considering NT-proBNP as both a categorical variable, using the median value as the cut-off level, and numerical variable. Study end points were in-hospital mortality, cardiac surgery and 1 year survival. RESULTS: NT-proBNP was an independent predictor of in-hospital mortality (OR 14.9 [95%C.I. 2.46-90.9]; P = .003). Levels below 2926 pg/mL were highly predictive of a favorable in-hospital outcome (negative predictive value 96.6%). Patients with higher NT-proBNP levels showed a significantly lower survival rate at 1 year follow-up (log-rank P = .005). NT-proBNP was strongly associated with chronic kidney disease (P < .001) and significantly higher in patients with prior chronic heart failure (P = .001). NT-proBNP was tightly related to staphylococcal IE (P = .001) as well as with higher CRP and hs-troponin I (P = 0.023, P < .001, respectively). CONCLUSION: Our results confirm the remarkable prognostic role of NT-proBNP in patients with IE and provide novel evidences of its multifaceted correlates in this unique clinical setting. Our data strongly support the incorporation of NT-proBNP into the current diagnostic work-up of IE.
No takes yet. Share an insight, caveat, or question.
Bertolino et al. (2022) conducted a cohort in Acute infective endocarditis (n=337). NT-proBNP > 1689 pg/mL vs. NT-proBNP ≤ 1689 pg/mL was evaluated on In-hospital mortality (OR 14.9, 95% CI 2.46-90.9, p=0.003). Elevated NT-proBNP levels independently predicted in-hospital mortality (OR 14.9) in patients with acute infective endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: